Dr. Eduardo Galvan (@CardioMty) header
Dr. Eduardo Galvan (@CardioMty) profile picture

Cardiologo Intervencionista, departamento de Hemodinamia hospital de cardiología UMAE 34, Monterrey NL, Mex. #UMAE34cathlab

Monterrey Nuevo León
Joined October 2013
Photo by Dr. Eduardo Galvan (@CardioMty)Photo by Dr. Eduardo Galvan (@CardioMty)Photo by Dr. Eduardo Galvan (@CardioMty)Photo by Dr. Eduardo Galvan (@CardioMty)Photo by Dr. Eduardo Galvan (@CardioMty)Photo by Dr. Eduardo Galvan (@CardioMty)Photo by Dr. Eduardo Galvan (@CardioMty)Photo by Dr. Eduardo Galvan (@CardioMty)Photo by Dr. Eduardo Galvan (@CardioMty)Photo by Dr. Eduardo Galvan (@CardioMty)
Dr. Eduardo Galvan retweeted
CHIP LATAM #México join us in this intiative @LAzzaliniMD @rickytiago @CiticMexico @solaci_online
1
7
15
644
Dr. Eduardo Galvan retweeted
I am very pleased to share our latest publication as first author on management of coronary artery perforations in the Journal of American College of Cardiology(JACC). Stepwise, case-based review from our UK centre. 🔗 jacc.org/doi/10.1016/j.jacca… #JACC #cardiology #intervention
3
42
198
14,374
Dr. Eduardo Galvan retweeted
Mitral implantation of the Sapien M3 valve at HCU Valladolid. One team, one direction: The patient. Thank you to everyone who makes these milestones possible. Worth every sacrifice. @sacyl @EdwardsLifesci @secardiologia @mariogago13 @AnestesiaHCUV
1
27
158
7,078
Dr. Eduardo Galvan retweeted
🗞️ Hot off the press: #STAR trial First randomized controlled trial comparing two different technical strategies in #CTO #PCI jacc.org/doi/10.1016/j.jacc.…
18
36
4
97
22,634
TAVI or TAVR? A timely #EHJVSHD viewpoint reviews the historical origins, guideline evolution, and semantic accuracy of transcatheter aortic valve therapy, arguing why TAVI best reflects the procedure performed👉🔗ow.ly/o78950XJrMZ @EHJVSHDEiC @PanichellaG @IndolfiCiro @ESC_President @EAPCIPresident
2
37
2
134
10,375
Dr. Eduardo Galvan retweeted
.@WHO published a guideline in JAMA on the use and indications of #GLP-1 therapies for the management of #obesity in adults. The guideline offers two conditional recommendations to inform clinical practice and health policy. Read the guideline: ja.ma/3MxvT40
1
59
3
196
21,714
Dr. Eduardo Galvan retweeted
Guidelines recommend dual antiplatelet therapy after CABG for acute coronary syndrome, but whether it reduces adverse events as compared with aspirin alone is unclear. Research findings from the TACSI trial are summarized in a new Quick Take video. nej.md/499wznZ
2
58
1
310
50,536
Dr. Eduardo Galvan retweeted
A must-read paper in #EHJ! Coronary revascularization: a long-term perspective. A State-of-the-Art review forecasting advancements by 2040, drawing on historical trends and recent breakthroughs. @escardio @ESC_Journals #CardioTwitter academic.oup.com/eurheartj/a…
6
105
6
258
50,946
Dr. Eduardo Galvan retweeted
ACTUALIZACIÓN: CONTRADICCIONES ENTRE PLANTA Y CONCESIONARIO Adquirí una Volkswagen Tiguan 2025 R-Line el 23 de julio 2025. Confié en la marca y en su seguridad. Hoy, después de 3 ingresos a garantía y casi 3 meses sin mi vehículo, sigo sin solución. @Volkswagen_MX @Profeco
2
15
1
10
731
Dr. Eduardo Galvan retweeted
Provocative study from the RENOVATE trialists and Samsung Med Cntr suggesting use of intravascular imaging may eliminate long-term diffs between CABG & PCI. Not definitive absent a powered RCT, but should be enough to mandate IVI in these pts, esp with class I guidelines. Agree?
12
64
5
217
28,768
Dr. Eduardo Galvan retweeted
Estrategia de reducción de stents frente a revascularización coronaria percutánea convencional en el IAMCEST: diseño del ensayo COPERNICAN #REC #Aheadofprint @sjorge4 @drassantos @EvaRumiz @AntonioGomezM21 @fer_iver @cardioyoguini @hect2701 @ignamatsant revespcardiol.org/es-estrate…
1
13
1
21
1,997
Dr. Eduardo Galvan retweeted
📢 NEW State-of-the-Art Review Advanced coronary imaging techniques—IVUS, OCT, NIRS, and CCTA—enable detailed assessment of plaque morphology, vulnerability, and therapeutic response. This comprehensive review by García-García et al. outlines current evidence and clinical implications. Read here: ow.ly/gxYH50Wtaso @hect2701 @sjorge4 @christosbouran1 #Cardiology #Atherosclerosis #CoronaryImaging
2
68
3
161
17,885
Dr. Eduardo Galvan retweeted
New in EuroIntervention🔥 SCAI/EAPCI/ACVC expert consensus on cardiogenic shock in women. A comprehensive, evidence-based guide to diagnosis, monitoring, and treatment—across CS etiologies and clinical settings. #europcr #eapci #cardiogenicshock ow.ly/fAn250VVpLr
39
72
6,299
Dr. Eduardo Galvan retweeted
Are pressure-based indices vessel agnostic? Pressure derived indices in the Left Main @achir76 @drkogallagher @DrOzanDemir @k_desilva @mattlkw @divaka_perera @ukHeartResearch @theBHF #cardiotwitter #AHAJournals ahajrnls.org/3H6YdY0
30
1
61
8,615
Dr. Eduardo Galvan retweeted
🔍🖊️ ¿Quiere escribir un artículo de revisión? ¡Aquí encontrará los mejores tips para organizar, analizar y comunicar su trabajo con claridad y precisión! 📚✨ ¡Que su revisión sea imprescindible! 🔬 🧩sciencedirect.com/science/ar…
80
228
11,273
Dr. Eduardo Galvan retweeted
🔥Just published🔥 "Catheter-based techniques for pulmonary embolism treatment" by @Costa_F_8, @MicariAntonio et al. ✅A detailed review on CDT & CDMT ✅Practical strategies for device selection, procedural planning & risk stratification ✅Insights from the PEERLESS trial 🔗 eurointervention.pcronline.c… #InterventionalCardiology #PulmonaryEmbolism #CDMT #CDT #PEERLESS #Cardiology
18
42
3,600
Dr. Eduardo Galvan retweeted
This review provides a practical outlook on catheter-directed therapies for pulmonary embolism, outlining optimal procedural planning, device selection, technical execution, evaluation of results, and management of complications. eurointervention.pcronline.c…
2
22
1
53
5,957
Dr. Eduardo Galvan retweeted
Read our updated review on coronary calcified nodules here 👉 sciencedirect.com/science/ar… @ClaraFdezCordon @esbrilakis @PCRonline @secardiologia @TCTMD @RevEspCardiol Graphical abstract 👉
1
30
1
85
5,113
Dr. Eduardo Galvan retweeted
Relevant calcified coronary artery disease may be present in ~20% of patients undergoing PCI, and it is known to add procedural challenges and risks. This State-of-the-Art review aims to present the contemporary clinical approach and procedural planning for patients with calcified lesions, describing the available tools and strategies. eurointervention.pcronline.c…
1
38
2
103
11,081
Our PPG review is out at @JACCJournals! I would like to thank the leadership and support of @yadersandoval @ColletCarlos @esbrilakis @BernardBruyne @CCAD_MHIF. Link: jacc.org/doi/10.1016/j.jacad…
1
20
4
81
12,905